BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12881882)

  • 1. Nelfinavir tolerated in HCV patients.
    AIDS Patient Care STDS; 2002 Dec; 16(12):617. PubMed ID: 12881882
    [No Abstract]   [Full Text] [Related]  

  • 2. Nelfinavir safe and effective in HIV/HCV patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.
    Robertson SM; Scarsi KK; Postelnick MJ; Lynch P
    Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic junctional bradycardia after treatment with nelfinavir.
    Landovitz RJ; Sax PE
    Clin Infect Dis; 1999 Aug; 29(2):449-50. PubMed ID: 10476763
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C and PIs.
    Albrecht H
    AIDS Clin Care; 2001 Oct; 13(10):97. PubMed ID: 11590923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelfinavir (Viracept).
    Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV agents. Nelfinavir levels during pregnancy.
    TreatmentUpdate; 2004; 16(3):5-6. PubMed ID: 17216835
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
    Schvarcz R; Rudbeck G; Söderdahl G; Ståhle L
    Transplantation; 2000 May; 69(10):2194-5. PubMed ID: 10852623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
    Brown LS; Kritz S; Chu M; Madray C
    J Subst Abuse Treat; 2006 Jun; 30(4):331-5. PubMed ID: 16716848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
    Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
    J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir access in Canada.
    TreatmentUpdate; 1998 Sep; 10(7):6, 8. PubMed ID: 11365783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological, virological and clinical response in patients infected with HIV after highly active antiviral therapy with nelfinavir: prospective cohort study].
    de Alarcón A; Viciana P; Lozano F; Vergara A; Pujol E; Barrera A; Pérez-Guzmán E; Colmenero MA; Hernández-Quero J; Márquez M; de la Torre J; Aliaga L; Suárez I; Gutiérrez-Ravé V; Torres-Tortosa M; Marín J; Valdayo MJ; Milla M;
    Enferm Infecc Microbiol Clin; 2003 Dec; 21(10):543-51. PubMed ID: 14642252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone appetite--using food to boost your Viracept.
    Clay PG
    Posit Aware; 2003; 14(4):29. PubMed ID: 12951947
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
    Burger DM; Bergshoeff AS; De Groot R; Gibb D; Walker S; Tréluyer JM; Hoetelmans RM;
    J Pediatr; 2004 Sep; 145(3):403-5. PubMed ID: 15343199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis coinfection and LPV/RTV.
    Carter M
    IAPAC Mon; 2004 Oct; 10(10):398. PubMed ID: 15801120
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-infections. Can hepatitis C virus help keep cholesterol levels low?
    TreatmentUpdate; 2006; 18(5):4-5. PubMed ID: 17205648
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
    BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients.
    Hennessy M; Clarke S; Spiers JP; Kelleher D; Mulcahy F; Hoggard P; Back D; Barry M
    Antivir Ther; 2004 Feb; 9(1):115-22. PubMed ID: 15040543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.
    Kempf DJ; King MS; Bernstein B; Cernohous P; Bauer E; Moseley J; Gu K; Hsu A; Brun S; Sun E
    J Infect Dis; 2004 Jan; 189(1):51-60. PubMed ID: 14702153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.